Magnesium in PDB 5g22: Plasmodium Vivax N-Myristoyltransferase in Complex with A Quinoline Inhibitor (Compound 26)
Enzymatic activity of Plasmodium Vivax N-Myristoyltransferase in Complex with A Quinoline Inhibitor (Compound 26)
All present enzymatic activity of Plasmodium Vivax N-Myristoyltransferase in Complex with A Quinoline Inhibitor (Compound 26):
2.3.1.97;
Protein crystallography data
The structure of Plasmodium Vivax N-Myristoyltransferase in Complex with A Quinoline Inhibitor (Compound 26), PDB code: 5g22
was solved by
V.Goncalves,
J.A.Brannigan,
A.Laporte,
A.S.Bell,
S.M.Roberts,
A.J.Wilkinson,
R.J.Leatherbarrow,
E.W.Tate,
with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:
Resolution Low / High (Å)
|
101.64 /
2.32
|
Space group
|
P 21 21 21
|
Cell size a, b, c (Å), α, β, γ (°)
|
57.970,
123.360,
179.370,
90.00,
90.00,
90.00
|
R / Rfree (%)
|
22 /
28.3
|
Other elements in 5g22:
The structure of Plasmodium Vivax N-Myristoyltransferase in Complex with A Quinoline Inhibitor (Compound 26) also contains other interesting chemical elements:
Magnesium Binding Sites:
The binding sites of Magnesium atom in the Plasmodium Vivax N-Myristoyltransferase in Complex with A Quinoline Inhibitor (Compound 26)
(pdb code 5g22). This binding sites where shown within
5.0 Angstroms radius around Magnesium atom.
In total 3 binding sites of Magnesium where determined in the
Plasmodium Vivax N-Myristoyltransferase in Complex with A Quinoline Inhibitor (Compound 26), PDB code: 5g22:
Jump to Magnesium binding site number:
1;
2;
3;
Magnesium binding site 1 out
of 3 in 5g22
Go back to
Magnesium Binding Sites List in 5g22
Magnesium binding site 1 out
of 3 in the Plasmodium Vivax N-Myristoyltransferase in Complex with A Quinoline Inhibitor (Compound 26)
Mono view
Stereo pair view
|
A full contact list of Magnesium with other atoms in the Mg binding
site number 1 of Plasmodium Vivax N-Myristoyltransferase in Complex with A Quinoline Inhibitor (Compound 26) within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:Mg1412
b:36.7
occ:1.00
|
O
|
A:LEU169
|
2.9
|
15.1
|
1.0
|
O2A
|
A:NHW1000
|
3.0
|
14.8
|
1.0
|
N
|
A:LYS172
|
3.0
|
24.4
|
1.0
|
O4A
|
A:NHW1000
|
3.2
|
15.5
|
1.0
|
N
|
A:LEU174
|
3.2
|
19.8
|
1.0
|
CB
|
A:LEU174
|
3.4
|
20.1
|
1.0
|
N
|
A:ARG173
|
3.4
|
22.3
|
1.0
|
CA
|
A:LYS172
|
3.5
|
25.5
|
1.0
|
CB
|
A:LYS172
|
3.5
|
25.1
|
1.0
|
C
|
A:LYS172
|
3.5
|
24.1
|
1.0
|
N
|
A:SER171
|
3.8
|
19.6
|
1.0
|
CA
|
A:LEU174
|
3.9
|
19.3
|
1.0
|
P1A
|
A:NHW1000
|
3.9
|
15.2
|
1.0
|
CD1
|
A:LEU174
|
3.9
|
21.9
|
1.0
|
C
|
A:ARG170
|
3.9
|
18.8
|
1.0
|
O1A
|
A:NHW1000
|
4.0
|
15.4
|
1.0
|
C
|
A:LEU169
|
4.0
|
16.8
|
1.0
|
CA
|
A:ARG170
|
4.1
|
17.5
|
1.0
|
CG
|
A:LEU174
|
4.1
|
20.7
|
1.0
|
CG1
|
A:VAL165
|
4.1
|
15.6
|
1.0
|
C
|
A:SER171
|
4.2
|
23.5
|
1.0
|
C
|
A:ARG173
|
4.2
|
21.7
|
1.0
|
O
|
A:LYS172
|
4.3
|
25.4
|
1.0
|
CA
|
A:ARG173
|
4.3
|
22.0
|
1.0
|
P2A
|
A:NHW1000
|
4.3
|
16.8
|
1.0
|
CA
|
A:SER171
|
4.4
|
21.4
|
1.0
|
N
|
A:ALA175
|
4.5
|
18.4
|
1.0
|
O
|
A:ARG170
|
4.5
|
18.5
|
1.0
|
N
|
A:ARG170
|
4.5
|
17.0
|
1.0
|
O3A
|
A:NHW1000
|
4.6
|
15.4
|
1.0
|
CG
|
A:LYS172
|
4.6
|
27.5
|
1.0
|
O6A
|
A:NHW1000
|
4.7
|
16.1
|
1.0
|
C
|
A:LEU174
|
4.7
|
19.1
|
1.0
|
CG2
|
A:VAL165
|
4.8
|
16.2
|
1.0
|
CB
|
A:VAL165
|
4.9
|
16.9
|
1.0
|
CD
|
A:LYS172
|
5.0
|
27.2
|
1.0
|
|
Magnesium binding site 2 out
of 3 in 5g22
Go back to
Magnesium Binding Sites List in 5g22
Magnesium binding site 2 out
of 3 in the Plasmodium Vivax N-Myristoyltransferase in Complex with A Quinoline Inhibitor (Compound 26)
Mono view
Stereo pair view
|
A full contact list of Magnesium with other atoms in the Mg binding
site number 2 of Plasmodium Vivax N-Myristoyltransferase in Complex with A Quinoline Inhibitor (Compound 26) within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
B:Mg1411
b:33.9
occ:1.00
|
O2A
|
B:NHW1000
|
2.7
|
16.9
|
1.0
|
N
|
B:LYS172
|
2.9
|
21.0
|
1.0
|
O4A
|
B:NHW1000
|
3.0
|
14.8
|
1.0
|
O
|
B:LEU169
|
3.0
|
20.6
|
1.0
|
N
|
B:LEU174
|
3.1
|
18.5
|
1.0
|
N
|
B:ARG173
|
3.3
|
21.6
|
1.0
|
CB
|
B:LEU174
|
3.5
|
18.2
|
1.0
|
CA
|
B:LYS172
|
3.5
|
21.3
|
0.5
|
CA
|
B:LYS172
|
3.5
|
21.4
|
0.5
|
C
|
B:LYS172
|
3.6
|
21.2
|
1.0
|
P1A
|
B:NHW1000
|
3.6
|
16.8
|
1.0
|
CB
|
B:LYS172
|
3.6
|
21.8
|
0.5
|
CB
|
B:LYS172
|
3.6
|
22.0
|
0.5
|
N
|
B:SER171
|
3.6
|
19.9
|
1.0
|
CA
|
B:LEU174
|
3.8
|
17.7
|
1.0
|
O1A
|
B:NHW1000
|
3.8
|
18.7
|
1.0
|
C
|
B:SER171
|
4.0
|
20.5
|
1.0
|
CG
|
B:LEU174
|
4.0
|
18.4
|
1.0
|
C
|
B:ARG170
|
4.0
|
20.5
|
1.0
|
C
|
B:ARG173
|
4.0
|
20.3
|
1.0
|
P2A
|
B:NHW1000
|
4.1
|
14.5
|
1.0
|
CA
|
B:ARG173
|
4.1
|
21.9
|
1.0
|
CD1
|
B:LEU174
|
4.1
|
18.4
|
1.0
|
C
|
B:LEU169
|
4.2
|
19.2
|
1.0
|
CA
|
B:SER171
|
4.2
|
20.5
|
1.0
|
O3A
|
B:NHW1000
|
4.2
|
16.0
|
1.0
|
CA
|
B:ARG170
|
4.2
|
19.5
|
1.0
|
N
|
B:ALA175
|
4.3
|
16.7
|
1.0
|
CG1
|
B:VAL165
|
4.3
|
14.8
|
1.0
|
O6A
|
B:NHW1000
|
4.5
|
14.7
|
1.0
|
O
|
B:LYS172
|
4.5
|
20.4
|
1.0
|
C
|
B:LEU174
|
4.5
|
17.1
|
1.0
|
CG
|
B:LYS172
|
4.5
|
22.8
|
0.5
|
CG
|
B:LYS172
|
4.6
|
23.3
|
0.5
|
N
|
B:ARG170
|
4.7
|
18.7
|
1.0
|
O
|
B:ARG170
|
4.7
|
21.0
|
1.0
|
CG2
|
B:VAL165
|
4.8
|
15.4
|
1.0
|
CB
|
B:VAL165
|
4.9
|
15.5
|
1.0
|
|
Magnesium binding site 3 out
of 3 in 5g22
Go back to
Magnesium Binding Sites List in 5g22
Magnesium binding site 3 out
of 3 in the Plasmodium Vivax N-Myristoyltransferase in Complex with A Quinoline Inhibitor (Compound 26)
Mono view
Stereo pair view
|
A full contact list of Magnesium with other atoms in the Mg binding
site number 3 of Plasmodium Vivax N-Myristoyltransferase in Complex with A Quinoline Inhibitor (Compound 26) within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
C:Mg1411
b:29.8
occ:1.00
|
O2A
|
C:NHW1000
|
2.7
|
17.7
|
1.0
|
O4A
|
C:NHW1000
|
2.8
|
14.3
|
1.0
|
N
|
C:LYS172
|
3.0
|
20.8
|
0.5
|
N
|
C:LYS172
|
3.0
|
20.8
|
0.5
|
N
|
C:LEU174
|
3.1
|
19.4
|
1.0
|
O
|
C:LEU169
|
3.1
|
18.7
|
1.0
|
CB
|
C:LEU174
|
3.3
|
18.0
|
1.0
|
N
|
C:ARG173
|
3.3
|
21.7
|
1.0
|
N
|
C:SER171
|
3.5
|
18.4
|
1.0
|
P1A
|
C:NHW1000
|
3.6
|
17.7
|
1.0
|
CA
|
C:LYS172
|
3.6
|
21.6
|
0.5
|
CA
|
C:LYS172
|
3.7
|
21.6
|
0.5
|
C
|
C:LYS172
|
3.7
|
21.3
|
0.5
|
C
|
C:LYS172
|
3.7
|
21.3
|
0.5
|
CB
|
C:LYS172
|
3.7
|
21.6
|
0.5
|
CA
|
C:LEU174
|
3.8
|
17.8
|
1.0
|
P2A
|
C:NHW1000
|
3.8
|
15.7
|
1.0
|
O1A
|
C:NHW1000
|
3.8
|
19.0
|
1.0
|
CG
|
C:LEU174
|
3.9
|
18.2
|
1.0
|
CB
|
C:LYS172
|
3.9
|
21.6
|
0.5
|
C
|
C:ARG170
|
3.9
|
18.3
|
1.0
|
C
|
C:SER171
|
4.0
|
20.6
|
1.0
|
O3A
|
C:NHW1000
|
4.1
|
16.7
|
1.0
|
CD1
|
C:LEU174
|
4.1
|
17.4
|
1.0
|
C
|
C:ARG173
|
4.1
|
20.4
|
1.0
|
CA
|
C:SER171
|
4.1
|
20.2
|
1.0
|
CA
|
C:ARG170
|
4.1
|
17.5
|
1.0
|
CA
|
C:ARG173
|
4.2
|
21.2
|
1.0
|
C
|
C:LEU169
|
4.3
|
18.4
|
1.0
|
CG
|
C:LYS172
|
4.3
|
21.6
|
0.5
|
N
|
C:ALA175
|
4.3
|
17.2
|
1.0
|
O6A
|
C:NHW1000
|
4.4
|
15.3
|
1.0
|
O
|
C:LYS172
|
4.5
|
22.2
|
0.5
|
C
|
C:LEU174
|
4.5
|
17.7
|
1.0
|
CG1
|
C:VAL165
|
4.5
|
12.7
|
1.0
|
O
|
C:LYS172
|
4.6
|
22.1
|
0.5
|
O
|
C:ARG170
|
4.7
|
19.7
|
1.0
|
N
|
C:ARG170
|
4.7
|
17.8
|
1.0
|
CG2
|
C:VAL165
|
4.8
|
12.6
|
1.0
|
CG
|
C:LYS172
|
4.8
|
21.4
|
0.5
|
|
Reference:
V.Goncalves,
J.A.Brannigan,
A.Laporte,
A.S.Bell,
S.M.Roberts,
A.J.Wilkinson,
R.J.Leatherbarrow,
E.W.Tate.
Structure-Guided Optimization of Quinoline Inhibitors of Plasmodium N-Myristoyltransferase. Medchemcomm V. 8 191 2017.
ISSN: ISSN 2040-2503
PubMed: 28626547
DOI: 10.1039/C6MD00531D
Page generated: Sun Sep 29 04:35:07 2024
|